Candida albicans biofilms: more than filamentation. 2005

José L López-Ribot
Department of Medicine, Division of Infectious Diseases, The University of Texas Health Science Center at San Antonio, Texas Research Park, 15355 Lambda Drive, San Antonio, TX 78245, USA. ribot@uthscsa.edu

Candida albicans is the fungal species most commonly associated with biofilm formation in immunosuppressed patients. Recent work offers a fresh new look at the role of filamentation in C. albicans biofilm formation, and describes the application of a powerful tool for the molecular dissection of these important developmental processes.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D018441 Biofilms Encrustations formed from microbes (bacteria, algae, fungi, plankton, or protozoa) embedded in an EXTRACELLULAR POLYMERIC SUBSTANCE MATRIX that is secreted by the microbes. They occur on body surfaces such as teeth (DENTAL DEPOSITS); inanimate objects, and bodies of water. Biofilms are prevented from forming by treating surfaces with DENTIFRICES; DISINFECTANTS; ANTI-INFECTIVE AGENTS; and anti-fouling agents. Biofilm
D025141 Drug Resistance, Fungal The ability of fungi to resist or to become tolerant to chemotherapeutic agents, antifungal agents, or antibiotics. This resistance may be acquired through gene mutation. Antibiotic Resistance, Fungal,Antifungal Drug Resistance,Resistance, Antifungal Drug

Related Publications

José L López-Ribot
September 2007, Biological & pharmaceutical bulletin,
José L López-Ribot
April 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics,
José L López-Ribot
October 2007, Eukaryotic cell,
José L López-Ribot
August 2011, Current opinion in microbiology,
José L López-Ribot
September 2016, Microbiology and molecular biology reviews : MMBR,
José L López-Ribot
May 2024, G3 (Bethesda, Md.),
José L López-Ribot
March 2018, Critical reviews in microbiology,
José L López-Ribot
November 2014, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!